Parental attitudes toward newborn screening for Duchenne/Becker muscular dystrophy and spinal muscular atrophy

Molly F Wood1, Sarah C Hughes, Lauren P Hache

  • 1Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Muscle & Nerve
|December 6, 2013
PubMed

Insights

Parents strongly support including Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), and spinal muscular atrophy (SMA) in newborn screening (NBS). Continued discussion is warranted due to diagnostic and therapeutic advancements.

Area of Science:

  • Medical Genetics
  • Public Health
  • Pediatrics

Background:

  • Newborn screening (NBS) panel inclusion decisions should incorporate perspectives of affected families.
  • Assessing parent attitudes towards NBS for Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), and spinal muscular atrophy (SMA) is crucial.

Purpose of the Study:

  • To evaluate parent support for including DMD, BMD, and SMA in newborn screening panels.
  • To identify factors influencing parent attitudes regarding NBS for these neuromuscular disorders.

Main Methods:

  • A survey was conducted to gauge attitudes towards NBS for DMD, BMD, and SMA.
  • Parental attitudes were compared between families with affected children and expectant parents without a known family history.

Main Results:

  • Over 90% of both parent groups expressed strong support for NBS inclusion of DMD, BMD, and SMA.
  • Specifically, 95.9% of parents with affected children and 92.6% of expectant parents supported NBS for these conditions.

Conclusions:

  • There is substantial parental support for the inclusion of DMD, BMD, and SMA in newborn screening.
  • Ongoing advancements in diagnostics and therapeutics necessitate continued dialogue on expanding NBS panels for these conditions.
Abstract